Fortune MNC 500 India 2026 edition
Rank#160- Total income
- ₹4,512 Cr
- Profit
- ₹614 Cr
Last year #167
Please enter your name.
Please enter a valid email address.
Please select an issue type.
Please add a few details about the issue.
About Johnson & Johnson
Johnson & Johnson is a publicly listed company based in New Brunswick (United States) founded in 1886. Healthcare solutions are provided by Johnson Johnson globally. It operates on a Direct-to-Consumer (D2C) and Professional Services model in Healthcare and Consumer sectors. The company has 139,800 employees. Johnson & Johnson has completed 56 acquisitions, including 3dp.com, Abiomed and Actelion. Its chief executive, as recorded, is Joaquin Duato. Its website jnj.com draws about 2.4 million monthly visits. Johnson & Johnson offers products and services including Innovative Medicine, MedTech, and Acuvue Oasys Max 1-Day Multifocal. Its focus areas include Pharmaceuticals, Innovative Medicine, Medical Devices and MedTech. Its legal entity is Johnson & Johnson and its affiliates. Its competitors include GE Healthcare, Medtronic and Boston Scientific; 1 of its 3 listed competitors has raised funding.
Company details
Healthcare innovations are driven by Johnson Johnson through its focus on medicines and medical technology. Solutions are developed in areas such as oncology, immunology, neuroscience, and cardiopulmonary for its Innovative Medicine segment. The MedTech segment addresses cardiovascular, orthopaedics, surgery, and vision challenges with advanced technology. Operations are conducted across North America, EMEA, Asia Pacific, and Latin America, impacting global health equity and environmental sustainability. Social impact and caring initiatives are integrated into the companys mission to change health for humanity.
Johnson and Johnson is ranked #160 on the Fortune MNC 500 India (2026).
Recognitions & Rankings of Johnson & Johnson
Operational Areas
Key Metrics
- Annual Revenue$94.18 B (USD)6.03as on Dec 31, 2025
- Net Profit$26.8 B (USD)90.56as on Dec 31, 2025
- EBITDA$33.63 B (USD)19.41as on Dec 31, 2025
- Latest Funding Round$33.96M (USD), Debt – Conventional
Feb 2025
- InvestorsEuropean Union
& 1 more
- Employee Count139,800
- Investments & Acquisitions3dp.com
& 55 more
Associated legal entities of Johnson & Johnson
Johnson & Johnson is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson Surgical Vision India Private Limited CIN U24231KA2004PTC034235 | Active | 29 Jun 2004 | Bangalore, Karnataka | ₹732 Cr | 198 | 3 | View details |
| Johnson & Johnson Private Limited CIN U33110MH1957PTC010928 | Active | 05 Sep 1957 | Mumbai, Maharashtra | ₹4,461 Cr | 127 | 7 | View details |
Products & Services of Johnson & Johnson
Johnson & Johnson offers a comprehensive portfolio of products and services, including Innovative Medicine, MedTech, and Acuvue Oasys Max 1-Day Multifocal.
Innovative Medicine
Healthcare
Medicines are developed for oncology and immunology needs.
MedTech
Medical Technology
Technology is created for cardiovascular and surgical solutions.
Acuvue Oasys Max 1-Day Multifocal
Vision Care
Contact lenses are designed for astigmatism with multifocal support.
Funding Insights of Johnson & Johnson
- Total Rounds 3
- Last Round Debt – Conventional — $33.96M
- First Round $18.7M
(Nov 2018)
- Investors Count 2
All 3 funding rounds of Johnson Johnson with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $33.96M | Debt – Conventional | – | – | – |
| May 2023 | $582,554 | Grant | – | – | |
| Nov 2018 | $18.7M | Post-IPO | – | – |
Valuation history
2 investors in total: 2 institutional.
Investors in Johnson & Johnson
Johnson & Johnson has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Perkins Wolf & Mc Donnell.
All
Institutional
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
| pwmco.com |
Premium access
Investor details for Johnson Johnson
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Johnson & Johnson
The boards of the 2 registered companies of Johnson & Johnson currently have 9 directors; the longest-serving is Burzin Homi Shahana, appointed in 2015. 39 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Burzin Homi Shahana DIN 07246290 | Director | 24 Aug 2015 | 11 yrs 2 mo | Johnson & Johnson Surgical Vision India Private Limited |
| Ameya Madhav Joshi DIN 09819116 | Director | 30 Dec 2022 | 3 yrs 10 mo | Johnson & Johnson Private Limited |
| Anuj Virmani DIN 10274649 | Director | 28 Aug 2023 | 3 yrs 2 mo | Johnson & Johnson Private Limited |
| Muralidhar Venkata Karanam DIN 07496715 | Director | 08 Dec 2023 | 2 yrs 11 mo | Johnson & Johnson Private Limited |
| Surjeet Kumar Lamba DIN 10560289 | Director | 26 Mar 2024 | 2 yrs 7 mo | Johnson & Johnson Surgical Vision India Private Limited |
| Rohit Gulati DIN 10560293 | Director | 26 Mar 2024 | 2 yrs 7 mo | Johnson & Johnson Surgical Vision India Private Limited |
| Pushkar Purushottam Kulkarni DIN 10837726 | Director | 15 May 2025 | 1 yr 5 mo | Johnson & Johnson Private Limited |
| Shilpa Puskarlal Kedia DIN 10508350 | Director | 23 Jun 2025 | 1 yr 4 mo | Johnson & Johnson Private Limited |
| Ankur Jain DIN 11798077 | Additional Director | 30 Jun 2026 | 4 mo | Johnson & Johnson Private Limited |
People of Johnson & Johnson
789 people are tracked at Johnson & Johnson (353 in leadership, 11 in board & advisors, 425 in team); the tracked headcount is 139,800.
| Name | Role | Group |
|---|---|---|
Joaquin Duato | CEO | Leadership |
Travis Covington | Vp, Strategic Robotics R&d | Leadership |
Richard Tillyer | Global Head, Discovery, Product Development & Supply, Janssen Research and Development | Leadership |
Thomas O'Gara | Senior Director, Strategic Demand & Capacity Management | Leadership |
Hitesh Vora | Director | Leadership |
Deepak Bandyopadhyay | Director, Data Science, R&d Quality | Leadership |
Sue Hohenleitner | VP, Finance, Johnson & Johnson Innovation | Leadership |
Charles Nau | Director | Leadership |
Anand Narayanan | Director | Leadership |
Neema Kulkarni | Associate Director, Global Topical Healthcare | Leadership |
Alice Pizzelanti | Head Of Hr, Janssen US Commercial Centers Of Excellence | Leadership |
Anuj Terapanthi | IT Director - Platform Leader, Finance Data & Analytics | Leadership |
Chandra Branham | Senior Director, Payment & Care Delivery, Health Policy | Leadership |
Minh Miran | Global Sr. Director, Strategy & Operations | Leadership |
Hoang Lu (Jack) | Director | Leadership |
Bert Bruyninckx | Director | Leadership |
Juan Velez | IT Director | Leadership |
Liz Rivett | Director | Leadership |
Carol Boyne | Director | Leadership |
Wael Adhami | Vice President, Global Trade Controls | Leadership |
769 more people are available in the full profile.
Premium access
Complete people profiles for Johnson & Johnson
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Johnson & Johnson
Johnson & Johnson is a publicly listed company on the NYSE with ticker symbol JNJ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 May 2017
- Listed onVIE: JNJ
- Listed entityJohnson & Johnson
- Exchange sectorHealth technology
- ISINUS4781601046
- Share price$248.61 (-5.73% on the day) · 2026-10-13
- Market capitalisation$599.12B
- Price to earnings37.7
- EPS (diluted, trailing year)$6.59
- Dividend yield2.12%
- Volume (last session)16,645,813
Financials of Johnson & Johnson
Figures of Johnson & Johnson Surgical Vision India Private Limited, the primary company behind Johnson & Johnson, for FY 2025. Revenue was ₹732 Cr (+15% year on year). Net profit was ₹27.37 Cr (4% margin). EBITDA was ₹38.71 Cr (5% margin). Revenue has grown at a compounded annual rate of +26% over three years and +14% over five years.
- ₹732 CrRevenue · FY 2025 · +15% YoY
- ₹27.37 CrNet profit · 4% margin
- ₹38.71 CrEBITDA · 5% margin
- ₹4.19 CrPaid-up capital
- 198Employees (provident fund records)
- +26%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Exchange-reported annual figures
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $94.18B | $26.80B | $33.63B |
| 2024 | $88.82B | $14.07B | $28.16B |
| 2023 | $85.15B | $14.17B | $29.65B |
| 2022 | $80.06B | $17.94B | $28.18B |
| 2021 | $93.76B | $20.88B | $31.87B |
Balance sheet, profit and loss, cash flow and ratios of Johnson & Johnson Surgical Vision India Private Limited are on its company page.
Premium access
Detailed financial statements for Johnson & Johnson
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Johnson & Johnson
Johnson & Johnson has strategically engaged in corporate development activities, having acquired 56 companies. Notable acquisitions include 3dp.com, Abiomed and Actelion.
Acquisitions
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of antibody drug conjugates for the treatment of cancer | fireflybiologics.com | San Francisco, United States | 2022 | Jun 2026 | $1B | |
Next-generation tools for left-heart access are developed for cardiac treatments. | atraversemedical.com | Chicago, United States | 2022 | Apr 2026 | •••• | |
Precision therapeutics for cancer treatment are developed using targeted delivery. | haldatx.com | New Haven, United States | 2019 | Nov 2025 | $3.05B | |
A needle-free transdermal patch for self-applicable injectables is developed. | obaris.ch | Schlieren, Switzerland | 2024 | Sep 2025 | •••• | |
Developer of therapeutics for psychiatric and neurologic diseases | intracellulartherapies.com | New York, United States | 2002 | Jan 2025 | $14.6B | |
Implantable inter-atrial shunts are developed to treat chronic heart failure. | vwavemedical.com | Caesarea, Israel | 2009 | Aug 2024 | $600M | |
Therapeutics for dermatological conditions are developed and provided. | Wadenswil, Switzerland | 0 | May 2024 | $1.25B | ||
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed. | shockwavemedical.com | Santa Clara, United States | 2009 | Apr 2024 | $13.1B | |
Antibody-drug conjugates are developed for cancers and metabolic disorders. | ambrx.com | San Diego, United States | 2003 | Jan 2024 | $2B | |
Provider of catheter based left atrial appendage closure device | laminarlaa.com | Santa Rosa, United States | 2019 | Nov 2023 | $400M |
Premium access
Complete acquisition details for Johnson Johnson
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Johnson & Johnson
14 dated milestones of Johnson & Johnson across 140 years, from founding to its latest funding, stage changes and deals.
- Founded Johnson & Johnson is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $18.7M.
- Acquisition Acquires LAMINAR.
- Acquisition Acquires Ambrx.
- Acquisition Acquires Shockwave Medical.
- Acquisition Acquires Yellow Jersey Therapeutics.
- Acquisition Acquires V-Wave.
- Acquisition Acquires Intra-Cellular Therapies.
- Funding Latest funding round, Debt – Conventional, of $34.0M.
- Acquisition Acquires OBaris.
- Acquisition Acquires Halda Therapeutics.
- Acquisition Acquires Atraverse Medical.
- Acquisition Acquires Firefly Bio.
Competitors of Johnson & Johnson
Johnson & Johnson has 3 listed competitors in our database, 1 of them funded. They include GE Healthcare, Medtronic and Boston Scientific.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gehealthcare.com | 1892 | Chicago, United States | $29.13M | 16,700 | Materials management solutions are provided for healthcare organizations. | |
| medtronic.com | 1949 | Minneapolis, United States | 1,114 | Medical equipment for treating over 30 chronic diseases is developed. | ||
| bostonscientific.com | 1979 | Marlborough, United States | 63,359 | Wide range of medical devices |
Premium access
Detailed competitors of Johnson Johnson
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Johnson & Johnson
The website of Johnson & Johnson (jnj.com) receives about 2.4M visits a month and ranks #22,739 among all websites worldwide, #266 in Jobs and Employment.
- Monthly visits2.4M
▲ 18.6% vs previous month
- Unique visitors655.7K
per month
- Global rank#22,739
among all websites
- Category rank#266
Jobs and Career · Jobs and Employment
Visitor engagement
- Bounce rate40%
- Pages per visit5.5
- Average visit6 min 24 sec
- DevicesDesktop 74% · Mobile 26%
Similar websites
Websites whose visitors overlap most with Johnson & Johnson. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jobs.merck.com | jobs.merck.com | 100% | #165,475 | – | |
jnjcanada.com | jnjcanada.com | 99% | – | ||
careers.roche.com | careers.roche.com | 96% | #72,577 | – | |
careers.astrazeneca.com | careers.astrazeneca.com | 96% | #86,918 | – | |
| jobs.abbott | 96% | #64,576 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
Premium access
All 40 similar websites and full traffic analytics for Johnson & Johnson
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Johnson & Johnson (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Diagnostic and surgical products for women's healthcare are provided. | 1985 | Marlborough, Massachusetts, United States | USD 4.1 B | 7,060 |
Upgrade to premium
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Johnson & Johnson
Premium access
Complete news archive for Johnson Johnson
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Johnson & Johnson
Johnson & Johnson was founded in 1886 and raised its 1st funding round 132 years after it was founded.
Johnson & Johnson is headquartered in New Brunswick, United States. It is registered at New Brunswick, New Jersey, United States.
Joaquin Duato is the CEO of Johnson & Johnson, as recorded in our data.
Johnson & Johnson has 139,800 employees.
Annual revenue of Johnson & Johnson is $94.18B as on Dec 31, 2025.
Healthcare innovations are driven by Johnson Johnson through its focus on medicines and medical technology. Solutions are developed in areas such as oncology, immunology, neuroscience, and cardiopulmonary for its Innovative Medicine segment. The MedTech segment addresses cardiovascular, orthopaedics, surgery, and vision challenges with advanced technology. Operations are conducted across North America, EMEA, Asia Pacific, and Latin America, impacting global health equity and environmental sustainability. Social impact and caring initiatives are integrated into the companys mission to change health for humanity.
Johnson & Johnson's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Johnson & Johnson offers Innovative Medicine, MedTech, and Acuvue Oasys Max 1-Day Multifocal.
Yes, Johnson & Johnson is publicly traded on NYSE under the ticker symbol JNJ.
Johnson & Johnson has 2 investors. Key investors include European Union, and Perkins Wolf & Mc Donnell.
Johnson & Johnson is associated with 2 legal entities: Johnson & Johnson Surgical Vision India Private Limited, Johnson & Johnson Private Limited.